🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
0.8532
+0.0166 (1.98%)
At close: Nov 18, 2026, 4:00 PM EST
0.8532
0.00 (0.00%)
After-hours: Nov 18, 2026, 4:00 PM EST

Marker Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
9.0416.0719.1915.1111.7842.35
Cash & Short-Term Investments
9.0416.0719.1915.1111.7842.35
Cash Growth
-48.61%-16.28%27.01%28.26%-72.18%98.34%
Other Receivables
2.431.372.351.032.40
Receivables
2.431.372.351.032.40
Prepaid Expenses
0.640.660.480.991.852.48
Restricted Cash
0.390.97---1.15
Other Current Assets
----0.59-
Total Current Assets
12.519.0722.0217.1316.6245.98
Property, Plant & Equipment
-----22.15
Other Long-Term Assets
----17.8-
Total Assets
12.519.0722.0217.1334.4268.14

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
1.360.791.070.961.15.14
Accrued Expenses
0.240.32.191.911.273.33
Current Portion of Leases
-----0.62
Current Unearned Revenue
0.390.97---1.15
Other Current Liabilities
-0.20.20.215.412.66
Total Current Liabilities
22.273.463.077.7812.9
Long-Term Leases
-----11.25
Other Long-Term Liabilities
----7.04-
Total Liabilities
22.273.463.0714.8224.15

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.020.020.010.010.010.01
Additional Paid-In Capital
476.52475.96465.56450.33447.64442.1
Retained Earnings
-466.03-459.18-447.02-436.29-428.05-398.12
Shareholders' Equity
10.516.818.5614.0519.643.99
Total Liabilities & Equity
12.519.0722.0217.1334.4268.14

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-----11.87
Net Cash (Debt)
9.0416.0719.1915.1111.7830.48
Net Cash Growth
-48.61%-16.28%27.01%28.26%-61.35%235.15%
Net Cash Per Share
0.471.052.141.721.413.98
Filing Date Shares Outstanding
16.6716.6710.718.98.88.31
Total Common Shares Outstanding
16.716.6710.718.898.418.31
Working Capital
10.516.818.5614.058.8433.08
Book Value Per Share
0.631.011.731.582.335.29
Tangible Book Value
10.516.818.5614.0519.643.99
Tangible Book Value Per Share
0.631.011.731.582.335.29
Machinery
-----9.66
Construction In Progress
-----2.23
Leasehold Improvements
-----3.17
SEC Filings: 10-K · 10-Q